S.C. Beck

Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells

C. Begley, Y. Mitsuuchi, Y. Deng, 2017, Cell Death Discovery.